PEPG

Latest SEC Filings & News for PEPG

2 most recent filings and news items mentioning PEPG. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/PEPG/news?limit=20"

Pull PEPG filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 6, 2026Positive

PepGen reports Q2 2026 results, DSMB recommends dosing escalation.

Biotech company PepGen reported financial results affirming long-term solvency. It announced positive breakthroughs in its DM1 trial, including a Data Safety Monitoring Board's recommendation to escalate dosing due to the drug's promising safety profile.

View filing at SEC.gov →

RegulatoryMay 21, 2026Negative

PepGen presents EDO platform data for DM1 candidate PGN-EDODM1

PepGen Inc. released a May 2026 company presentation detailing clinical progress of its oligonucleotide therapy PGN-EDODM1 for myotonic dystrophy type 1, highlighting dose-dependent splicing correction from FREEDOM and FREEDOM2 trials. The company faces ongoing regulatory interac

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.